Erythrocyte glutamic oxaloacetic transaminase activity in patients with oral lesions.
D001219:Aspartate Aminotransferases / Q000097:blood*; D002613:Cheilitis / Q000201:enzymology; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology*; D005260:Female; D005928:Glossitis / Q000201:enzymology; D006801:Humans; D008297:Male; D008660:Metabolism / Q000187:drug effects; D009059:Mouth Diseases / Q000201:enzymology*; D011247:Pregnancy; D011248:Pregnancy Complications; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D011736:Pyridoxine / Q000494:pharmacology / Q000627:therapeutic use; D012256:Riboflavin / Q000494:pharmacology / Q000627:therapeutic use; D012257:Riboflavin Deficiency / Q000150:complications; D013268:Stimulation, Chemical; D013280:Stomatitis / Q000201:enzymology; D026681:Vitamin B 6 Deficiency / Q000150:complications
D011732:Pyridoxal Phosphate; D001219:Aspartate Aminotransferases; D011736:Pyridoxine; D012256:Riboflavin